Three and a Half Million Members of CVS
Caremark's Clients Now Enjoy Access to Clinical Weight Loss Program
With Proven Results, High Satisfaction
WOONSOCKET, R.I., March 14,
2025 /PRNewswire/ -- CVS Health® (NYSE: CVS) released
compelling data today from the CVS Weight
ManagementTM program in which participants
achieved more than 15% weight loss on average, including existing
anti-obesity medication users who succeeded in nearly doubling
their pre-program weight loss while working with program clinicians
on diet and lifestyle.1 Before enrolling in the CVS
Weight Management program, 70% of members were using a weight
management drug without any lifestyle or nutrition
support.1
The initial results demonstrate improved weight loss and high
program satisfaction for CVS Caremark clients' plan members trying
a lifestyle-first approach and additional clinical effectiveness
and cost savings for members receiving clinical support while
taking weight management medications like GLP-1s.
The CVS Weight Management program provides one-on-one support
from a dedicated registered dietitian in a virtual setting,
including personalized nutrition planning based on health needs,
social determinants of health, and cultural and individual
preferences, empowering members to develop sustainable habits for
achieving long-term weight loss. At the direction of plan
sponsors, the program can seamlessly integrate into a member's
existing pharmacy benefit.
"The data are clear: GLP-1 weight-loss drugs work
best when combined with nutrition, lifestyle support and proper
dosing2," said Dr. Michelle
Gourdine, Chief Medical Officer, CVS Caremark. "The CVS
Weight Management program is a clinically rigorous solution that
helps optimize the effectiveness of GLP-1s for weight loss for
those that use them. It also supports members in making changes to
improve weight and cardiometabolic health without medication to
help offset or achieve success without the use of medication."
CVS Caremark Clients Experience Significant Cost
Savings
CVS Caremark clients who adopted the CVS Weight
Management program spent up to 26% less on GLP-1
medications for weight-loss, compared to those clients who did not
adopt the program.1 The program is also leaving a
lasting impact, with 92% of participating plan members expressing
satisfaction after six months in the
program.1 These findings are especially compelling
when the list price of GLP-1 drugs, which are set by
the drug manufacturers, can easily cost thousands of dollars per
year per member.
As of February 1, 2025, the CVS
Weight Management program is now available to more than 3.5 million
CVS Caremark plan members. The influx in enrollment nods to proven
results in a program that is optimizing the effectiveness of
GLP-1 weight loss drugs while lowering overall plan
pharmacy costs.
In clinical trials, GLP-1 anti-obesity medications
showed the best outcomes when drug therapy was combined with
structured lifestyle support,2 such as those embedded in
the CVS Weight Management program.
Data Demonstrates Durable, Lifestyle-First Solutions for
Sustainable Health Outcomes
Despite FDA prescription drug
labeling recommendations to take GLP-1's in
combination with diet and physical activity, before enrolling in
the CVS Weight Management program, 70% of members were using a
weight management drug without any lifestyle or nutrition
support.1 After completing the program, the clinical
results for members are particularly striking:
- Before program enrollment nearly 30% of members had lost less
than 1 percent body weight on anti-obesity medication. These same
members lost on average 11.7% of body weight after enrollment.
That's 13x increase in total weight loss.1
- The program accelerated weight-loss and delivered best-in-class
results of average 20% weight loss for those with moderate success
prior to enrollment.1
- Members who chose to discontinue anti-obesity medication and
retain lifestyle support maintained 94% of their weight loss after
6 months.1
Results are derived from a population of 265,000 members from
2023-2024.
About CVS Health
CVS Health® is the leading health
solutions company, delivering care like no one else can. We reach
more people and improve the health of communities across America
through our local presence, digital channels and over 300,000
dedicated colleagues — including more than 40,000 physicians,
pharmacists, nurses and nurse practitioners. Wherever and whenever
people need us, we help them with their health — whether that's
managing chronic diseases, staying compliant with their medications
or accessing affordable health and wellness services in the most
convenient ways. We help people navigate the health care system —
and their personal health care — by improving access, lowering
costs and being a trusted partner for every meaningful moment of
health. And we do it all with heart, each and every day. Follow
@CVSHealth on social media.
Media contact
Phil
Blando
202-258-4978
Phillip.Blando@CVSHealth.com
1 CVS Health
Analytics, 2024. Weight Management Results. Data from August 2023
through September 2024. 265K Total Covered Lives, as of
9/30/24.
|
2 Wilding, J. P., et al (2021).
Once-Weekly Semaglutide in Adults with Overweight or Obesity. New
England Journal of Medicine, 384(11), 989–1002.
https://doi.org/10.1056/nejmoa2032183
|
View original content to download
multimedia:https://www.prnewswire.com/news-releases/cvs-weight-management-program-improves-health-outcomes-while-also-lowering-costs-302401630.html
SOURCE CVS Health